The deal priced below last closing price of $48.33. Morgan Stanley and Goldman Sachs are acting as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IONS:
- Ionis Pharmaceuticals announces $500M common stock offering
- Ionis Pharmaceuticals management to meet with Oppenheimer
- JPMorgan healthcare analysts hold an analyst/industry conference call
- Truist biotech analysts hold an analyst/industry conference call
- Ionis Pharmaceuticals price target raised to $55 from $50 at JPMorgan